The industry’s hopes that a US federal spending bill would reduce the impact of the Food and Drug Administration’s (FDA’s) deeming regulations were disappointed this week when a Senate committee approved a version that makes no reference to tobacco products.
Passed unanimously by the Senate Appropriations Committee, the measure remained silent not only on e-cigarettes but on tobacco products in general. ...
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.